Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial
JMIR Research Protocols · 2025-10-02 · 14 · e73926
DOI: 10.2196/73926 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2025-10-02. Written by Rebecca L Ford and 14 co-authors. Institution: Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. Major MEDLINE topics: Probiotics, Bifidobacterium longum subspecies infantis, Lactiplantibacillus plantarum, Synbiotics. Cited 1 times so far (Crossref); 39 references. The full text is freely available in PubMed Central. Funded by: Gates Foundation.
Abstract (original language)
Background
Childhood mortality in low- or middle-income countries (LMICs) remains a major public health concern, with infections being a leading cause of infant death. Probiotics have shown promise in reducing infection-related morbidity and mortality in preterm infants, but their use in newborns born at or near term in LMICs requires further investigation.
Objective
This study aims to assess the feasibility, safety, and initial outcomes of administering 1 of 2 synbiotic formulations or a placebo to newborns in the Eastern Highlands Province of Papua New Guinea.
Methods
Following ethics approvals in 2018 and 2019, and receipt of the synbiotic preparations in September 2020, healthy neonates (
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
- Microbiology Research Group, Institute of Innovation, Science and Sustainability, Federation University, Churchill, Australia.
- Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute Australia, Perth, Australia.
- Centre for Child Health Research, University of Western Australia, Perth, Australia.
- Discipline of Paediatrics, Medical School, University of Western Australia, Perth, Australia.
ORCID profiles: Rebecca L Ford, Andrew R Greenhill, Joycelyn Sapura, Amelia Koata, Mary Dreyam, Tilda Orami, Joe Jude, Madeline Ong, Wendy Kirarock, Dorcas Joseph, Geraldine Masiria, Celestine Aho, William S Pomat, Anita H J van den Biggelaar, Peter C Richmond
Funding
- Gates Foundation
Cite
APA
Ford, R. L., Greenhill, A. R., Sapura, J., Koata, A., Dreyam, M., Orami, T., Jude, J., Ong, M., Kirarock, W., Joseph, D., Masiria, G., Aho, C., Pomat, W. S., van den Biggelaar, A. H. J., & Richmond, P. C. (2025). Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 14, e73926. https://doi.org/10.2196/73926
Vancouver
Ford RL, Greenhill AR, Sapura J, Koata A, Dreyam M, Orami T, et al. Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025;14:e73926. doi:10.2196/73926
BibTeX
@article{Ford2025,
author = {Ford, Rebecca L and Greenhill, Andrew R and Sapura, Joycelyn and Koata, Amelia and Dreyam, Mary and Orami, Tilda and Jude, Joe and Ong, Madeline and Kirarock, Wendy and Joseph, Dorcas and Masiria, Geraldine and Aho, Celestine and Pomat, William S and van den Biggelaar, Anita H J and Richmond, Peter C},
title = {Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
volume = {14},
pages = {e73926},
doi = {10.2196/73926}
}
EUVIMED